Live Events
Upcoming Events
Past Events
Algorithms
Breast Cancer
2022
2023
2024
2025
GI
2022
2023
2024
2025
GU
2023
2024
Gynecology
2024
Hematology
2023
2024
Lung Cancer
2023
2024
Melanoma
2023
2024
NET
2024
Supportive Care
2024
TNBC
Conferences
AACR
2023
ASCO
2022
2023
2024
ASH
2022
2023
2024
ESMO
2022
2023
2024
GI ASCO
2024
2025
GU ASCO
2023
2024
SABCS
2022
2023
2024
WCLC
2022
2023
2024
Journal club
Breast
2022
2023
2024
GI
2023
2024
GU
2023
2024
2025
Hematology
2023
2024
Lung Cancer
2024
Tox Check
ADC
Anti-VEGF & Anti-EGFR
CAR-T
Contact
Live Events
Upcoming Events
Past Events
Algorithms
Breast Cancer
2022
2023
2024
2025
GI
2022
2023
2024
2025
GU
2023
2024
Gynecology
2024
Hematology
2023
2024
Lung Cancer
2023
2024
Melanoma
2023
2024
NET
2024
Supportive Care
2024
TNBC
Conferences
AACR
2023
ASCO
2022
2023
2024
ASH
2022
2023
2024
ESMO
2022
2023
2024
GI ASCO
2024
2025
GU ASCO
2023
2024
SABCS
2022
2023
2024
WCLC
2022
2023
2024
Journal club
Breast
2022
2023
2024
GI
2023
2024
GU
2023
2024
2025
Hematology
2023
2024
Lung Cancer
2024
Tox Check
ADC
Anti-VEGF & Anti-EGFR
CAR-T
Contact
Search
Journal club
Breast Cancer
Explore All
>
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
Dr. Hope Rugo discusses Capivasertib FDA Approval based on CAPItello-291 Study
EMERALD lead to the Elacestrant FDA Approval - OncBrothers in discussion w/ Dr. Virginia Kaklamani
EMERALD Ph III Study in discussion w/(now FDA Approved) Dr. Aditya Bardia
DESTINY-Breast04 Study Discussion with Dr. Shanu Modi
GI
Explore All
>
FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant
FRESCO2 Study: FDA Approval of Fruquintinib for Refractory Colorectal Cancer
MOUNTAINEER Study in discussion w/ Dr. Tanios Bekaii-Saab
The NICHE-2 Study Discussion with Dr. Myriam Chalabi
GU
Explore All
>
FDA Approval of Subcutaneous Nivolumab CheckMate-67T - Subcutaneous Nivo vs. Intravenous (IV) Nivo
Breakthrough in Bladder Cancer: FDA approval – Enfortumab Vedotin + Pelbrolizumab with Dr. Tom Powles
EV-103 Study by Dr. Jonathan Rosenberg led to the FDA Approval of Enfortumab + Pembrolizumab
Hematology
Explore All
>
AGAVE-201 Study - FDA Approval of Axatilimab for Chronic Graft-versus-Host Disease (cGVHD)
Zanubrutinib – FDA Approval, Efficacy & Safety Profile – Discussion with Dr. Shadman
Polatuzumab FDA Approval in DLBCL (POLARIX) & SWOG S1826 Nivo vs. BV in Hodgkin’s Lymphoma Dr. Jonathan Friedberg
Lung Cancer
Explore All
>
DeLLphi-301 - FDA Approval of Tarlatamab in Patients with Previously Treated Small Cell Lung Cancer (SCLC)
AEGEAN Study - FDA Approval of Durvalumab in Resectable Non-Small Cell Lung Cancer
Your experience on this site will be improved by allowing cookies
Cookie Policy
Allow cookies